| Trial ID: | L4465 |
| Source ID: | NCT00133718
|
| Associated Drug: |
Combined Lifestyle Intervention And Optimisation Of Pharmacological Treatment
|
| Title: |
A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Combined lifestyle intervention and optimisation of pharmacological treatment
|
| Outcome Measures: |
Primary: Reduction in 10-year absolute CHD risk, 2-year | Secondary: Effects on cardiovascular events, 5-year|Effects on hospitalisations, 5-year|Effects on CV risk markers (HbA1c, lipids, blood pressure, inflammation, etc), 2 years and 5 years|Effects on health related quality of life, 2 years and 5 years
|
| Sponsor/Collaborators: |
Sponsor: Asker & Baerum Hospital | Collaborators: Rikshospitalet University Hospital|University Hospital, Aker|Sahlgrenska University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
120
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2002-01
|
| Completion Date: |
2012-05-29
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-24
|
| Locations: |
Asker and Baerum Hospital, Medical Department, RUD, 1309, Norway
|
| URL: |
https://clinicaltrials.gov/show/NCT00133718
|
